General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

People

Under the leadership of Joseph Jimenez, the Novartis Executive Committee (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.

Download the Novartis organizational structure (23 KB)

  • Joseph Jimenez
    Chief Executive Officer of Novartis

    Read biography:

  • Juergen Brokatzky-Geiger, Ph.D.
    Head of Human Resources

    Read biography:

  • David Epstein
    Division Head, Novartis Pharmaceuticals

    Read biography:

  • Mark C. Fishman, M.D.
    President of the Novartis Institutes for BioMedical Research (NIBR)

    Read biography:

  • George Gunn, MRCVS
    Division Head, Novartis Animal Health
    Head, Novartis Corporate Responsibility

    Read biography:

  • Harry Kirsch
    Chief Financial Officer of Novartis AG

    Read biography:

  • Brian McNamara
    Division Head, Novartis OTC

    Read biography:

  • Andrin Oswald, M.D.
    Division Head, Novartis Vaccines and Diagnostics

    Read biography:

Other Members of Senior Management

  • Erwin Vanhaecke, Ph.D.
    Head Novartis Group Quality

    Read biography: